Esther Torres to Child
This is a "connection" page, showing publications Esther Torres has written about Child.
Connection Strength
0.310
-
Torres EA, Torres-Cintron M, Velazquez S, Vendrell R, Del Valle A, P?rez CM. Prevalence of Inflammatory Bowel Diseases in Puerto Rico: A Health Care Claims Analysis of an Insured Population. P R Health Sci J. 2021 Sep; 40(3):103-109.
Score: 0.112
-
Torres EA, Mart?nez NA, Mart?nez P, Ayala AM, Milli?n D, Rivera C, Saad? M, Davis J. Profile of the average organ non-donor: can it be used predictively? P R Health Sci J. 2014 Sep; 33(3):129-31.
Score: 0.069
-
Mel?ndez JD, Larregui Y, V?zquez JM, Carlo VL, Torres EA. Medication profiles of patients in the University of Puerto Rico inflammatory bowel disease registry. P R Health Sci J. 2011 Mar; 30(1):3-8.
Score: 0.054
-
Viruet EJ, Torres EA. Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis. P R Health Sci J. 1998 Sep; 17(3):297-300.
Score: 0.023
-
Vargas CA, Rubio CE, Rodr?guez-Trinidad A, Torres EA. Idiopathic hemochromatosis: a study in a large Puerto Rican family. P R Health Sci J. 1993 Dec; 12(4):283-6.
Score: 0.016
-
Gonz?lez-Keelan C, Arce V, Ortiz AP, Torres EA, Lojo JJ. Increase in the number of IBD surgical resections at the Puerto Rico Medical Center: A brief report. P R Health Sci J. 2012 Dec; 31(4):223-6.
Score: 0.015
-
Moreno JM, Rubio CE, Torres EA. [Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980-87]. Bol Asoc Med P R. 1989 Jun; 81(6):214-8.
Score: 0.012
-
S?nchez JM, Maldonado JC, Torres EA, Rivera C. Infliximab in Hispanics: characterization of response to infliximab in an ethnic minority with Crohn's disease. P R Health Sci J. 2005 Mar; 24(1):11-7.
Score: 0.009